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Dendritic cells (DC) play a key role in the adaptive immune response due to their
ability to present antigens and stimulate naïve T cells. Many bacteria and viruses
can efficiently target DC, resulting in impairment of their immunostimulatory function
or elimination. Hence, the DC compartment requires replenishment following infection
to ensure continued operational readiness of the adaptive immune system. Here,
we investigated the molecular and cellular mechanisms of inflammation-induced DC
generation. We found that infection with viral and bacterial pathogens as well as Toll-like
receptor 9 (TLR9) ligation with CpG-oligodeoxynucleotide (CpG-ODN) expanded an
erythropoietin (EPO)-dependent TER119+CD11a+ cell population in the spleen that
had the capacity to differentiate into TER119+CD11chigh and TER119−CD11chigh cells
both in vitro and in vivo. TER119+CD11chigh cells contributed to the conventional DC
pool in the spleen and specifically increased in lymph nodes draining the site of local
inflammation. Our results reveal a so far undescribed inflammatory EPO-dependent
pathway of DC differentiation and establish a mechanistic link between innate immune
recognition of potential immunosuppressive pathogens and the maintenance of the DC
pool during and after infection.
Keywords: infection, inflammation, erythropoietin, dendritic cell, extramedullary hematopoiesis, TER119, toll-like
receptor
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INTRODUCTION
Dendritic cells (DC) are professional antigen-presenting cells
crucial for coordinating and regulating immune responses. The
ability of DC to prime naïve T cells depends on the antigen-
presenting function of DC, but also on their ability to provide
stimulating cytokines. The origin and the development of DC
has been intensively studied (1). Based on their ontogeny, the
DC family can be subdivided into four cell types: Langerhans
cells, plasmacytoid DC (pDC), conventional DC (cDC) and
monocyte-derived DC (2). Langerhans cells are seeded in the
skin during embryonic development or derive from monocytes
during inflammation (3, 4). cDC and pDC both originate from
a pluripotent hematopoietic stem cell in the bone marrow
(5). pDC fully develop in the bone marrow and only mature
in the periphery (6). cDC differentiate via bone marrow-
resident common myeloid progenitors (CMP), macrophage
DC progenitors (MDP), and common DC progenitors (CDP)
into pre-DC that leave the bone marrow to the blood
circulation and seed peripheral tissues (5–8). In the periphery,
cDC fully differentiate into cDC subpopulations cDC1 and
cDC2 depending on the transcription factors BATF3 and
IRF4 (9), respectively, and acquire subset-specific functions. In
mouse spleen, cDC subpopulations can be distinguished by a
CD4−CD8+CD11b− (cDC1) and CD4+CD8−CD11b+ (cDC2)
surface phenotype (2). Monocyte-derived DC develop under
inflammatory conditions from an early myeloid progenitor cell
(8). It is important to note that even during later stages of lineage
commitment DC development retains a certain plasticity, as for
example pDC precursors can re-differentiate into cDC in the
periphery (10).
Many bacteria (e.g., Salmonella enterica, Yersinia
enterolytica, Helicobacter pylori) (11) and viruses (e.g.,
Human Immunodeficiency Virus (HIV), herpesviruses,
paramyxoviruses) (12–15) interfere with the initiation of
an adaptive immune response by targeting or even eliminating
DC. Also, the number of splenic DC is critically reduced in
severe polymicrobial infections (16). Hence, it is desirable to
replenish the DC pool as early as possible in the course of
an infection in order to keep the adaptive immune system
effective. The recognition of viral and bacterial pathogens by
pattern recognition receptors of the innate immune system
triggers a robust inflammatory response that increases the
numbers of hematopoietic stem and progenitor cells, resulting in
expansion of myeloid lineages (17). Interestingly, inflammatory
activation of the hematopoietic system is not limited to the bone
marrow, but certain infections can induce the egress of early
progenitor cells from the bone marrow to the spleen or expand
spleen-resident progenitor cells to allow for extramedullary
hematopoiesis (18–20). Extramedullary hematopoiesis critically
depends on the presence of macrophages, on activation of
pattern recognition receptors such as Toll-like Receptor 9
(TLR9), on MyD88/TRIF signaling and on STAT1 expression in
myeloid cells, and is characterized by accumulation of TER119+
cells of the red blood cell lineage in the spleen (19, 21–23). Of
note, certain pathogens suppress extramedullary hematopoiesis
as part of their immune evasion program (19), indicating an
important role for this phenomenon in the innate immune
defense. However, a mechanistic link between the response to
infection and the massive expansion of erythroid TER119+ cells
is elusive.
In this study, we investigated extramedullary hematopoiesis
and the replenishment of the DC pool after infection. We
identified inflammatory erythropoietin-dependent TER119+
cells in the spleen with the potential to differentiate into
CD11chigh cells in vitro and in vivo. TER119 expression was
transiently maintained on bona fide DC in the spleen and in
the draining lymph nodes. Hence, our results describe a so far
unknown pathway of inflammatory DC development in response
to infection that is active during extramedullary hematopoiesis.
MATERIALS AND METHODS
Mice
Female C57BL/6 mice were purchased from Elevate Janvier (Le
Genest Saint Isle, France) at the age of 7 weeks and housed at
the animal facility of the Max von Pettenkofer-Institute for at
least 1 week before being used in experiments. TLR9−/− mice
(24) and 1DC mice (25) were bred at the animal facilities of
the II. Medizinische Klinik, Klinikum Rechts der Isar, Technical
University Munich, and the Institute for Immunology, Ludwig-
Maximilians-University Munich, respectively. 1DC mice were
generated by crossing CD11cCre mice (26) to mice that express
the diphteria toxin α chain (DTA) under control of a loxP-
flanked stop cassette from the ROSA26 locus (R-DTA mice)
(27) leading to direct expression of DTA in DC and constitutive
elimination of more than 95% of all cDCs and pDCs (25). The
DC compartment remains depleted during inflammation (28).
Experiments with knockout mice were performed with sex- and
age-matched animals. Mice were housed at specified pathogen–
free (SPF) health status in individually ventilated cages at 21–
22◦C and 39–50% humidity in groups of 5 animals. Animal
experiments were approved by the responsible state government.
Treatments
Experiments were performed with a dose of 20 nmol CpG-
ODN 1826 (Tib Molbiol, Berlin, Germany) which reproducibly
induced moderate extramedullary hematopoiesis, as in previous
studies (23). The mice were anesthetized with isoflurane and
CpG-ODN was injected subcutaneously (s.c.) into the right hind
footpad in order to model local infection, as previously described
(29). For in vivo blockade of EPO, the mice were injected
intravenously (i.v.) with 250 µg monoclonal rat anti-mouse EPO
antibody (clone 148438; cat#MAB959) or rat immunoglobulin
G (IgG)2a isotype control (clone 54447; cat#MAB006) (R&D
Systems) in phosphate-buffered saline (PBS) at day 2 and day 4,
as described before (22). For CD115 blockade, mice were injected
with 250 µg in vivo ReadyTM anti-mouse CD115 antibody
(anti-CSF-1R, clone AFS98; cat# 40-1152) and in vivo ReadyTM
Rat IgG2a Isotype Control (clone 2A3; cat# 40-4321) (Tonbo
biosciences) i.v. at days 0, 2, and 4 post CpG-ODN treatment.
For the adoptive transfer of TER119+CD11a+ cells, footpad
injection was performed as described above in congenic wt and
1DC animals. On day 6, TER119+CD11c−CD11a+ cells were
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harvested from the wt animals and transferred via tail vein
injection to the 1DC animals. Each animal received a transfer
of 1.5× 106 cells.
Infections
Pathogen infections were performed as follows: vaccinia
virus Western Reserve, 105 plaque-forming units (PFU)
intraperitoneally (i.p.) (30); MCMV (bacterial artificial
chromosome pSM3fr-derived Smith strain), 106 PFU i.v. (19);
MHV-68, 5× 104 PFU intranasally (i.n.) after ketamine/xylazine
anesthesia (31); L. monocytogenes (strain 1actA), 5 × 103
colony-forming units (CFU) i.v. (19); and P. aeruginosa (strain
PA01), 2× 106 CFU i.v.
Cell Staining and Sorting
In order to obtain single cell suspensions, spleens and lymph
nodes were cut into pieces and digested with 400 U/ml
Collagenase D (Roche) and 100 µg / ml DNase I (Roche) in
RPMI 1640medium for 1 hour at 37◦C. EDTA to a concentration
of 0.01M was added for 5min to stop the enzymatic reactions.
The digest was passed through a 70µm cell strainer and
cells were washed with PBS at 300 g for 7min. In order to
lyse mobile mature erythrocytes for the analysis of organ-
resident TER119+ cells, we used ACK lysing buffer (155mM
ammonium chloride, 10mM potassium bicarbonate, 0.1mM
EDTA, adjusted to pH = 7.2–7.4 using hydrochloric acid) in all
of our experiments. For flow cytometry and cell sorting, cells
were incubated with Mouse BD Fc BlockTM (BD Pharmingen)
in FACS buffer, washed, and stained with monoclonal antibodies
specific to CD3e (clone 145-2C11) conjugated with PerCP-Cy5.5,
CD11a (M17/4) PE and APC, CD11b (M1/70) FITC, CD11c
(N418) APC, CD19 (eBio1/D3) APC, CD41 (MWReg30) FITC,
CD71 (RI7 217.1.4) PE, CD115 (AFS98) PerCP-Cy5.5, CD117
(c-kit; 2B8) eFluor710, CD135 (A2F10) PE, CD172a (Sirp-α;
P84) APC, Gr-1 (RB6-8C5) FITC, TER119 (TER-119) APC
and PE, B220 (RA2-6B2) PE, Sca-1 (D7) PerCP-Cy5.5, MHC-II
(M5/114.15.2) FITC, and NK 1.1 (PK136) PE for 20min on ice
(all antibodies were purchased from eBiosciences). After staining,
cells were washed twice at 300 g for 7min and resuspended in
buffer containing propidium iodide (PI) for exclusion of dead
cells. Cell acquisition was performed on a FACSCaliburTM or a
FACSCanto IITM unit (Becton Dickinson) using CellQuest ProTM
or FACSDivaTM software, and data were analyzed using FlowJo
(Tree Star Inc.). Cell sorting was performed on a FACSAriaTM
unit (Becton Dickinson).
Cytokine Detection
For DC IL-12 production, splenocyte-derived DC (SDDC) and
bone marrow-derived DC (BMDC) were plated in 6-well dishes
at a density of 1 × 106 cells / well and were stimulated for
12 h with CpG-ODN. Cell culture supernatants were collected
and stored at −80 ◦C until analysis. For detection of IL-
12p40 a commercially available kit (R&D; cat#MP400) was used
according to the instructions of the manufacturer. For EPO
detection, blood serum was isolated using Z-Gel 1.1ml serum
preparation tubes (Sarstedt, cat# 41.1378.005) according to the
manufacturer’s instructions. Serum samples were probed for
EPO using a commercially available kit (R&D; cat#MEP00B)
according to the instructions of the manufacturer.
In vitro Differentiation Assays
DC were generated from spleens following the protocol for
BMDC production with GM-CSF or Flt3-L (32). In brief, femora
and tibiae were removed and cleaned of muscle tissue, disinfected
for 3min in 70% ethanol and then rinsed with PBS. The bones
were cut with scissors at the epiphyses, the marrow was flushed
with PBS using a sterile 27-gauge needle and passed through
a 70µm cell strainer. Erythrocytes were lysed in bone marrow
and splenocyte single cell suspensions with ACK lysing buffer
for 3min at room temperature, the cells were washed once
and plated at a density of 4 × 105 cells / ml in 10ml RPMI
supported with 200 U/ml GM-CSF (PeproTech, cat#315-03)
on 100mm diameter Petri dishes. At day 3 of culture another
10ml medium with 200 U/ml GM-CSF were added. After 6
days 10ml of cell culture were removed, cells pelletized, re-
suspended in 10ml fresh medium containing 200 U/ml GM-
CSF and retransferred to the remaining culture. For culture with
Flt3-L, cells were plated in 10ml RPMI with 20 ng / ml Flt3-L
(PeproTech, cat#250-31L) at a density of 1.8 × 106 cells / ml on
100mm diameter Petri dishes and FLT-3L cultures were analyzed
at day 10 without any further treatment. Colony formation
assays were performed usingMethoCult GFM3434 following the
manufacturer’s instructions (STEMCELL Technologies).
Cytospins and Giemsa Staining
For cytospins, 8 × 104 cells in PBS were spun onto microscope
slides at 750 rpm for 2min with slow acceleration using a
Cytospin III (Shandon). Cells were fixed for 5min in methanol
before staining with a Giemsa-solution for 20min. After washing
with water microscope slides were air-dried and stored at 4◦C.
Magnetic Bead Enrichment
At day 10 after CpG-ODN footpad injection, single cell
suspensions from draining popliteal lymph nodes were enriched
for CD11c+ cells using mouse CD11c MicroBeads UltraPure
according to the manufacturer’s instructions (Miltenyi Biotec).
Quantitative Reverse Transcription-PCR
(qRT-PCR)
For analysis of epor and gypa expression TaqMan gene
expression assays Mm 00833882_m1 and Mm 00494848_m1
were used, respectively.
Statistics
Statistical analysis was performed using Prism5
(GraphPad Software).
RESULTS
Sterile Inflammation Induces the
Expansion of Erythropoietin-Dependent
DC in the Spleen
Given the fact that many pathogens target DC (11–15), we
hypothesized that the DC pool has to be replenished upon
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inflammation. In order to evaluate the spleen’s DC generation
potential in the course of inflammation, we stimulated mice with
the synthetic TLR9 agonist CpG-oligodeoxynucleotide (CpG-
ODN). Six days later, we harvested the spleens of stimulated
and control mice and cultured the splenocytes for 10 days
in the presence of granulocyte–monocyte colony-stimulating
factor (GM-CSF). Consistent with an inflammation-induced
stimulatory effect, cultures from CpG-ODN–treated animals
yielded significantly more cells than cultures from control
or TLR9-deficient animals (Figure 1A). The obtained cells
(splenocyte-derived dendritic cells; SDDC) presented the distinct
morphology of DC (Figure 1B) and could be separated into
immature and mature populations according to the expression of
major histocompatibility complex (MHC) class II molecules like
DC generated from bone marrow culture (BMDC) (Figure 1C
and Figures S1A,B). In addition, after overnight stimulation with
CpG-ODN, SDDC up-regulated co-stimulatory molecule CD40
and CD86 expression and produced IL-12 amounts similar to
BMDC (Figures 1D,E). Hence, we asked whether CpG-ODN-
induced inflammation also resulted in expansion of the DC
compartment in vivo. Strikingly, the proportion of CD11chigh
splenocytes at day 6 following CpG-ODN stimulation increased
by ∼35% (Figure 1F and Figure S1C). All other lineages
examined contracted proportionally upon CpG-ODN injection,
except for TER119+ cells, which dominated the cellularity of the
spleen after CpG-ODN injection. TER119 is expressed during
late stages of red blood cell differentiation, i.e., from early
proerythroblasts to mature erythrocytes (33). Nevertheless, we
tested whether increased number of CD11c+ and TER119+ cells
were linked and found a distinct TER119+CD11chigh population
that appeared in CpG-ODN–stimulated spleens but not in
the bone marrow (Figure 1G and Figures S1D,F). Additional
analysis revealed that these TER119+CD11chigh splenocytes
expressed MHC class II and either CD8 or CD11b similar to
conventional DC in the spleen.
Erythropoietin (EPO) is known to expand the TER119+
cell compartment. Since TER119+ cell numbers increased upon
sterile inflammation, we probed for EPO serum levels after
CpG-ODN injection (Figure 1H). CpG-ODN administration
significantly increased EPO levels at day 4 after stimulation,
similar to what was observed after bacterial infection (22).
In order to study the role of increased EPO levels during
inflammation for the generation of TER119+CD11chigh cells,
we stimulated mice with CpG-ODN and depleted EPO in vivo
using a monoclonal antibody. EPO depletion abolished the
increase in TER119+ cells and resulted in complete loss of
TER119+CD11chigh cells (Figure 1I). Of note, depletion of EPO
also resulted in a significant decrease in total DC numbers
in the spleen upon CpG-ODN administration (Figure 1J).
Although clearly additional EPO-independent DC generation
mechanisms are in place after treatment with CpG-ODN, these
data implicate EPO as a positive factor in DC development
during inflammation. We confirmed this finding in vitro by
culturing splenocytes from CpG-ODN–treated mice and found
that in vivo EPO-depletion significantly reduced the number of
DC generated from GM-CSF culture (Figure 1K). In summary,
we found that sterile inflammation increased systemic EPO levels
and enhanced the DC generation capacity in the spleen by EPO-
dependent and -independent mechanisms.
Inflammation Induces TER119+CD11a+
Cells That Can Differentiate Into Erythroid
or Myeloid Cells
Because EPO contributed to the capacity of the spleen
to generate DC and was required for the occurrence of
TER119+CD11chigh cells during inflammation, we investigated
whether TER119+ cells accumulating in the spleen after
TLR9-ligation could differentiate into DC in vitro. We
observed that CD11a, the αL subunit of the integrin LFA-1,
discriminated two populations, i.e., TER119+CD11a− and
TER119+CD11a+, in the inflammation-induced TER119+
compartment (Figure 2A), as was previously shown (34).
A subpopulation among TER119+CD11a+ cells already
expressed low to intermediate levels of CD11c (Figure 2B).
To exclude cells that were already positive for CD11c from
our further analysis, we sorted TER119+CD11c−CD11a− and
TER119+CD11c−CD11a+ cells from the spleen of CpG-ODN–
stimulated animals and cultured them with GM-CSF for 10
days (Figure S1E). The TER119+CD11c−CD11a+ cells had
5-fold greater capacity to generate CD11c+ myeloid colonies
than the TER119+CD11c−CD11a− cells (Figure 2C). As
TER119+CD11c−CD11a+ cells showed potential to differentiate
into myeloid cells, we analyzed these cells for surface markers
that are expressed by myeloid progenitor cells (Figure 2D).
We found expression of Sca-1, c-kit, CD172a (Sirp-α) and
CD115 (MCSFR) on TER119+CD11a+ cells isolated from the
spleen, but not on TER119+CD11a− cells. CD135 (FLT-3) and
Gr-1 expression was only detectable on a small proportion
of TER119+CD11a+ cells. CD115 differentially controls the
development of myeloid cell populations (35). In order to test
whether CD115 blockade affects the expansion of TER119+ cells,
we administered anti-CD115 antibody. As expected, CD115
blockade reduced the numbers of splenic macrophages but
not of DC (Figure S2) (36). The number of TER119+ cells
after CpG-ODN treatment was not affected by anti-CD115
administration (Figure 2E), excluding a major role for CD115 in
the expansion of the TER119+ cell compartment.
Because TER119+CD11a+ cells expressed with TER119 a
red blood cell marker, we probed for further markers of
early and late stages of erythroid development. Only a minor
fraction of TER119+CD11a+ cells expressed CD41 (platelet
glycoprotein IIb [alpha(IIb)]), a marker of early erythropoiesis,
while late stage erythroid marker transferrin receptor CD71
was highly expressed (Figure 2F). Due to the mixed surface
phenotype of erythroid and myeloid progenitor cells displayed
by TER119+CD11a+ splenocytes, we tested whether these
cells present the ability to differentiate into both myeloid
and erythroid lineages. We performed colony formation assays
and cultured TER119+CD11a+ splenocytes with EPO or GM-
CSF. The number of colonies generated was comparable under
both conditions (Figure 2G). We asked whether the obtained
CD11c+ myeloid cells in culture retained erythroid marker gene
expression and probed for expression of EPO receptor (epor)
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FIGURE 1 | CpG-ODN stimulation induces an EPO-dependent increase in DC in the spleen. (A–E) C57BL/6 controls and TLR9-deficient mice (TLR9−/−) received a
single dose of CpG-ODN. At day 6 post stimulation, harvested spleens were homogenized and splenocytes (4 × 105 cells/ml) were cultured with GM-CSF for 10
days. (A) Graph shows number of DC obtained in culture. (B) Giemsa staining of splenocyte culture derived from CpG-ODN–treated C57BL/6 mice. (C) Surface
phenotype of cells from splenocyte culture as determined by flow cytometry. DC generated from bone marrow (BMDC) were included as controls. Representative dot
blots are shown. (D,E) DC derived from splenocyte culture (SDDC) and from bone marrow culture (BMDC) were stimulated with CpG-ODN. (D) Representative
histograms show expression of CD86 and CD40 on DC. Numbers indicate MFI (median (SD)). (E) Bar graphs show IL-12p40 in cell culture supernatant. (F,G)
C57BL/6 mice were stimulated with CpG-ODN and splenocytes were examined by flow cytometry at day 6 post treatment. (F) Splenocytes were stained for canonical
lineage markers. Graph shows %-change of indicated populations compared to untreated controls. (G) Blots show surface phenotype of CD3−CD19− splenocytes.
Data of the animal representing the median of n = 5 animals are shown. (H) EPO levels in blood serum at the indicated time points after CpG-ODN treatment. (I–K)
C57BL/6 mice were stimulated with CpG-ODN and received monoclonal anti-erythropoietin antibody (α-Epo) or isotype control (Iso). Graphs show (I) proportion of
TER119+ cells in the splenic DC compartment, (J) total number of DC in the spleen at day 6 post stimulation and (K) number of DC after culture of splenocytes (5 ×
105 cells/ml) with GM-CSF for 10 days. (A–K) Representative data of at least 3 experiments with n = 3–5 animals/group are shown. (A,E,H–K) Bar graphs show
mean (SD). One-way ANOVA with Bonferroni’s post test (A,I) or Student’s t test were performed (E,H,J,K). Statistical significance is indicated by * = p < 0.05,
**** = p < 0.0001, ns = p > 0.05.
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FIGURE 2 | The TER119+CD11a+ cell pool harbors potential to differentiate
into myeloid cells. (A–H) C57BL/6 mice were stimulated with CpG-ODN.
(A) Blots show surface phenotype of splenocytes at day 6 post treatment.
Data of the animal representing the median of n = 5 animals are shown.
(B) Representative histogram showing surface expression of CD11c on
TER119+CD11a− and TER119+CD11a+ splenocytes at day 6 post
CpG-ODN treatment. Proportion of CD11c+ cells (mean (SD)) and MFI
(median (SD)) of CD11c expression on the indicated populations are shown.
(C) Colony formation assay from TER119+CD11c−CD11a− and
TER119+CD11c−CD11a+ cells that were sorted from the spleens of
CpG-ODN–stimulated mice. (D) Representative histograms showing surface
phenotype of TER119+CD11a− and TER119+CD11a+ splenocytes at day 6
post treatment for myeloid progenitor cell markers. Proportion of marker
positive cells (mean (SD)) and MFI (median (SD)) of the respective markers on
the indicated populations are shown. (E) CpG-ODN-treated mice were
injected with anti-CD115 antibody or isotype control. Graph shows number of
TER119+ cells at day 6 post CpG-ODN treatment. (F) Representative
histograms showing surface phenotype of TER119+CD11a− and
TER119+CD11a+ splenocytes at day 6 post CpG-ODN treatment for erythroid
cell markers. Proportion of CD41+ cells and CD71+ cells (mean (SD)) and MFI
(median (SD)) of CD41 and CD71 expression on the indicated populations are
shown. (G) Colony formation assay with TER119+CD11a+ cells cultured with
(Continued)
FIGURE 2 | EPO or GM-CSF. (H) Relative expression of epor and gypa
transcripts in CD11c+ cells derived from TER119+CD11a+ cells after culture
with GM-CSF for 10 days compared to BMDC. (A–H) Representative data of
at least 3 experiments with n = 4–5 animals/group are shown. (C,E,G,H) Bar
graphs show mean (SD). Student’s t test was performed. Statistical
significance is indicated by *** = p < 0.0001, ns = p > 0.05.
and glycophorin A (gypa) transcripts by quantitative reverse
transcription–PCR (qRT-PCR). CD11c+ myeloid cells derived
from TER119+CD11a+ splenocytes had 30,000- and 8,000,000-
fold higher expression of epor and gypa, respectively, compared
to DC derived from bone marrow (Figure 2H).
In summary, our data suggest that inflammation induces the
expansion of TER119+CD11a+ cells in the spleen that have the
potential to differentiate into myeloid cells.
TER119+CD11chigh Cells Contribute to the
DC Compartment Upon Local Inflammation
Having shown the capacity of TER119+CD11a+ splenocytes
to differentiate into CD11c+ myeloid cells, we wanted to
know whether this differentiation pathway would also be
active in the local inflammatory environment. We injected
CpG-ODN subcutaneously into mouse footpads and observed
substantially increased cellularity in the draining lymph nodes,
peaking at day 10 post injection (Figure 3A), associated with
an increased number of DC (Figure 3B), as was previously
shown (29). We analyzed the DC compartment in the draining
lymph node following CpG-ODN stimulation and found that
TER119+CD11chigh cells were proportionally increased at day
6 post treatment (Figure 3C). Hence, inflammation-induced
TER119+CD11chigh cells are detectable both in the spleen and
in the peripheral lymph nodes in vivo.
Interestingly, TER119+CD11chigh cells represented only a
minor proportion of the whole DC population in the draining
lymph nodes compared to CD8+ or CD4+ DC subsets.
Furthermore, TER119+CD11chigh cells peaked in the lymph
nodes at day 6 and decreased until day 10, when mature DC
numbers peaked. Also, the expression level of TER119 on lymph
node DC was low compared to TER119+CD11a+ splenocytes or
TER119+CD11chigh cells in the spleen (Figure S3). Therefore, we
hypothesized that TER119+CD11chigh cells further differentiate
and lose their erythroid marker. In fact, we observed that
TER119+CD11a+ splenocytes gradually lost TER119 expression
during differentiation with GM-CSF in vitro (Figure 3D), while
cultures supported by Flt3-L maintained TER119 expression
during conversion to immature CD11c+ cells (Figure 3E).
However, we were unable to detect TER119+CD11a+ cells
in lymph nodes following CpG-ODN treatment. To explore
whether TER119+CD11chigh cells in the draining lymph nodes
could be derived from TER119+CD11a+ found in the spleen, we
transferred TER119+CD11a+ splenocytes from wild-type (wt)
donor mice to recipient mice that are constitutively depleted of
DC due to diphtheria toxin expression in CD11c+ cells (1DC
mice) and therefore present an empty niche (Figure 3F) (25). We
injected CpG-ODN into the footpads of both the congenic wt
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FIGURE 3 | TER119+CD11chigh cells contribute to the DC compartment in
the draining lymph node upon local inflammation. (A–C) Mice were injected
with a single dose of CpG-ODN into one footpad. Graphs show (A) cell count
of the contralateral (contra) and draining (drain) lymph nodes at day 10 post
stimulation, (B) total number of DC in lymph nodes, (C) proportion of
B220−CD11c+CD11bhigh Gr-1+ (Gr-1), CD4+, CD8+ and TER119+CD11c+
DC subsets in the lymph nodes at day 6 and day 10 post stimulation. nd = not
examined. Representative data of at least 3 experiments with n = 5
animals/group are shown. (D,E) TER119+CD11a+ splenocytes from
CpG-ODN treated mice were cultured with GM-CSF or FLT3-L. (D) Graph
shows proportion of TER119+ cells in culture with GM-CSF at the indicated
time points. (E) Representative blots showing TER119 and MHC-II expression
on CD11c+ cells after culture with Flt3-L. (F) Experimental setup for the
adoptive transfer of TER119+CD11a+ splenocytes from congenic wt mice into
CpG-ODN–stimulated mice that are deficient for DC (1DC). (G) Donor-derived
(Continued)
FIGURE 3 | cells from the draining lymph node were gated for CD11c.
Representative histogram shows TER119 expression and frequency of
TER119+ cells within the CD11c gate (mean (SD)). n = 3 animals. (A–D) Bar
graphs show mean (SD). (A–C) Student’s t test was performed. Statistical
significance is indicated by ** = p < 0.01, *** = p < 0.0001, ns = p > 0.05.
donor and 1DC recipient mice to create the local inflammatory
environment. At day 6 post stimulation, we transferred
TER119+CD11a+ splenocytes from the wt animals to the 1DC
recipients, and at day 10 we analyzed the draining lymph
node. We detected donor-derived CD11c+ cells only in 1DC
mice that had received TER119+CD11a+ cells. A proportion of
these cells retained TER119 expression (Figure 3G), suggesting
that TER119+CD11a+ splenocytes could differentiate into
TER119+CD11c+ and TER119−CD11chigh cells in the draining
lymph nodes in vivo.
Infection-Induced Inflammation Generates
TER119+CD11chigh Cells
Finally, we examined whether expansion of TER119+CD11a+
cells and TER119+CD11chigh cells was a result of isolated
TLR9-ligation with CpG-ODN or would also occur during
infection-induced inflammation. After infection with a poxvirus
(vaccinia virus Western Reserve), a β-herpesvirus (murine
cytomegalovirus, MCMV) and a murine γ-herpesvirus (murine
gammaherpesvirus 68, MHV-68) TER119+CD11a+ cells
became readily detectable in the spleen (Figures 4A,B).
Accordingly, splenocyte cultures from MCMV-infected
mice yielded more DC in vitro (Figure 4C), and more DC
including TER119+CD11chigh cells could be detected in vivo
(Figures 4D,E). Bacterial pathogens such as intracellular Listeria
monocytogenes and extracellular Pseudomonas aeruginosa also
expanded TER119+CD11a+ cells (Figure 4F). Finally, we
tested whether induction of extramedullary hematopoiesis
only occurs once in naïve individuals, or re-occurs after
repeated TLR-ligation. We stimulated mice with CpG-ODN
and repeated the procedure after three weeks (Figure 4G). The
proportion of TER119+CD11a+ splenocytes in mice that had
received CpG-ODN twice and in mice that were stimulated
once was comparable, indicating that TLR ligation can trigger
extramedullary hematopoiesis recurrently. In summary,
we have found that inflammation induced EPO-dependent
TER119+CD11a+ cells that could differentiate into TER119+
and TER119− DC contributing to the replenishment of the DC
pool in the spleen and draining lymph nodes after infection.
DISCUSSION
Dendritic cells are critical for the initiation of adaptive immune
responses. Consequently, many bacteria and viruses specifically
target DC causing functional paralysis or deletion of DC in
order to evade eradication (11, 13–15, 37). As a result, DC
populations must be replenished following pathogen infection
to ensure operational readiness of the adaptive immune system.
In fact, we found an increased potential of spleen homogenates
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FIGURE 4 | Viral and bacterial infections induce the expansion of TER119+
inflammatory DC. (A) Mice were infected with vaccinia virus Western Reserve.
Blots show TER119 and CD11a expression on splenocytes at day 6
post-infection. Data of the animal representing the median of n = 5 animals
are shown. (B–E) Mice were infected with mouse cytomegalovirus (MCMV) or
MHV-68. Graphs show (B) proportion of TER119+CD11a+ splenocytes at day
(Continued)
FIGURE 4 | 6 (MCMV) and day 17 (MHV-68) post-infection, (C) number of DC
in splenocyte culture from MCMV-infected mice after 10 days with GM-CSF,
(D) number of DC in spleens, and (E) number of TER119+CD11c+ cells in the
spleen after infection with MCMV. (F) Mice were infected with Listeria
monocytogenes (Listeria) and Pseudomonas aeruginosa (P.a.). Graphs show
proportion of TER119+CD11a+ cells in the spleen. (G) Mice were stimulated
with CpG-ODN. Three weeks later, mice were left untreated or received a
second dose of CpG-ODN, and were compared to naïve mice receiving
CpG-ODN. Bar graphs show proportion of TER119+CD11a+ cells at day 6
after second stimulation. (B–G) Representative data of at least 3 experiments
with n = 5 animals/group are shown. Bar graphs show mean (SD). Student’s t
test was performed. Statistical significance is indicated by * = p < 0.05, ** =
p< 0.01, *** = p < 0.0001.
to generate DC in vitro and increased splenic DC numbers
in vivo after stimulation of mice with synthetic TLR9 ligand
CpG-ODN. Most likely several myeloid progenitors contribute
to the expansion of the DC compartment upon inflammation.
We observed an increase in TER119+ cells indicating the
activation of extramedullary hematopoiesis, as was described
after stimulation with TLR7 and TLR9 ligands as well as after
infection with bacteria (Salmonella spp., Ehrlichia spp.) and virus
(mouse cytomegalovirus) (19, 21–23, 38–40). Subsequently, we
found that TER119 was also detectable on the surface of a small
proportion of CD11chigh cells. These TER119+CD11c+ cells
expressed MHC class II and CD8 or CD11b, therefore exhibiting
the distinct surface markers of conventional DC. Though
inflammation increased the numbers of TER119+CD11c+ cells,
a low level of TER119+ expression on myeloid cells can also be
observed in the steady-state (41).
Fulminant inflammation can result in a syndrome called
hemophagocytosis, in which phagocytes engulf other
hematopoietic cells. Thus, phagocytosis of erythrocytes or
of TER119+ progenitor cells can result in a positive signal
for TER119 after intracellular staining of DC (42, 43). We
used surface staining to detect TER119 on the cell membrane
of CD11chigh splenocytes upon inflammation. Nevertheless,
it is conceivable that DC acquire TER119 from other cells
through extravesicular particles, similar to the acquisition of
MHC complexes by so-called MHC cross-dressing. Though
these phenomena might contribute to phenotypically identical
TER119+CD11c+ cells, Dash et al. (34) and we identified an
inflammatory TER119+CD11a+ population in the spleen,
that had the potential to give rise to erythroid or CD11c+
myeloid colonies depending on the cytokine profile that they
were exposed to in our experiments. TER119+CD11a+ cells
differentiated into functional DC in vitro if cultured with GM-
CSF or FLT3-L, and into CD11chigh cells in vivo after transfer
into DC-deficient mice, downregulating TER119 expression
during this process, which suggests that TER119 expression
on DC is a remnant of earlier TER119+ differentiation stages.
Since co-expression of TER119 and CD11c might only be a
short transient state, it may well be that the small number
of TER119+CD11c+ cells underestimates the contribution
of inflammation-induced TER119+CD11a+ cells to the DC
compartment. Future studies using genetic tools will trace
TER119 expression in CD11c+ cells. At this point it remains
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unclear whether individual TER119+CD11a+ cells have the
plasticity to differentiate into both the erythroid or myeloid
lineage, or if cells within this population are already committed
for one of the lineages. From our data it appears that only
a minor fraction of TER119+CD11a+ cells differentiated
into DC, because not all seeded cells converted into DC in
vitro, and peak TER119+CD11a+ cell numbers greatly exceed
splenic DC numbers in vivo. Further investigations using
single cell technologies will have to address the plasticity of
TER119+CD11a+ cells.
Inflammation-induced extramedullary erythropoiesis
depends on EPO. We found increased systemic EPO levels at
day 4 after TLR9 ligation. EPO was absolutely required for the
expansion of TER119+CD11a+ cells and TER119+CD11chigh
cells in the spleen. It is conceivable that elevated EPO
levels during inflammation induced TER119 expression on
conventional CD8+ and CD11b+ DC subsets. However,
TER119+ DC were mostly detectable in the draining lymph
node after localized inflammation, while EPO levels increase
systemically. Also, while EPO injection or overexpression of
human EPO in transgenic mice expands the splenic DC pool
(44), our data show that EPO depletion in CpG-ODN–treated
mice decreased the total number of DC in the spleen significantly
and reduced the number of DC obtained from splenocyte culture
in vitro. In summary, these data suggest that EPO-dependent
and -independent mechanisms contribute to DC development
upon inflammation.
Finally, we were able to demonstrate that TER119+CD11chigh
cells are induced not only during sterile inflammation but also
after infection with bacterial and viral pathogens, for example
after infection with cytomegalovirus, a pathogen known to
induce extramedullary hematopoiesis and to impair DC function
(13, 19, 45, 46). These findings led us to the conclusion that the
expansion of TER119+CD11a+ cells is a general inflammatory
mechanism triggered by viral or bacterial pathogens in
order to maintain the DC compartment after infection. As
part of the innate immune response to inflammation, it is
conceivable that the induction of extramedullary hematopoiesis
and TER119+CD11a+ cells occurs recurrently after infection.
In fact, we have found that repeated CpG-ODN injection does
not affect the expansion of the TER119+CD11a+ cell pool,
suggesting that TLR ligation might trigger replenishment of the
DC pool by default. CpG-ODN and mouse cytomegalovirus
are recognized by TLR9 (47), and up to date only TLR7 and
TLR9 have been shown to induce extramedullary hematopoiesis
and TER119+ splenocytes (23, 39, 40). Nevertheless, pathogens
produce numerous ligands for pattern recognition receptors.
Interestingly, it was shown that IL-12 is sufficient for the
induction of extramedullary hematopoiesis (48). Hence, IL-12
induction by pattern recognition receptor signaling might be the
trigger for the induction of extramedullary hematopoiesis and the
replenishment of the DC compartment.
It is important to note that TER119 is commonly used
as a lineage marker to exclude erythroid cells in cell
sorting experiments. This technicality and the fact that
TER119+CD11chigh cells seem to be a transient differentiation
state after an inflammatory stimulus probably explains why
TER119+ DC have so far escaped attention. Taken together, our
data indicate that EPO-dependent inflammatory myeloid cells in
spleen and lymph nodes that are transiently marked by TER119
expression contribute to the replenishment of the DC pool in
response to an infection.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The animal study was reviewed and approved by Regierung von
Oberbayern, licensing numbers: 70/08, 50/09, 97/12.
AUTHOR CONTRIBUTIONS
HE, AH, and AS performed experiments and analyzed the data.
GG and HA provided materials, performed experiments, and
analyzed the data. DV provided mice and intellectual expertise.
MM provided intellectual expertise. ZR and LD provided
intellectual expertise and wrote the paper. UK and TS provided
intellectual expertise and funded the study. WR and SJ conceived
the study, designed, performed and analyzed experiments, wrote
the manuscript, and funded the study. All authors discussed the
data and edited the manuscript.
FUNDING
This work was financed by the Studienstiftung des Deutschen
Volkes (SJ), NGFN grant #01GS0801 (LD, UK), the Bayerische
Forschungsstiftung via Forprotect TH-1 and TH-2 (ZR, UK).
ACKNOWLEDGMENTS
We thank Natalie Röder and the Animal Facility of the Max
von Pettenkofer-Institute for excellent technical support, Werner
Göbel and Andreas Götz for L. monocytogenes and help with its
propagation, Michael Hogardt for providing the P. aeruginosa,
as well as Marc Dalod and Stipan Jonjic for helpful discussions.
We acknowledge support from the German Research Foundation
(DFG) and the Open Access Publication Fund of Charité –
Universitätsmedizin Berlin.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2020.01627/full#supplementary-material
Figure S1 | Splenocyte culture and lineage characterization in spleen after
CpG-ODN stimulation. (A,B) C57BL/6 received a single dose of CpG-ODN. At
day 6 post stimulation, harvested spleens were homogenized and splenocytes (4
× 105 cells/ml) were cultured with GM-CSF. As control, bone marrow cells from
untreated animals were cultured with GM-CSF. After 10 days in culture,
splenocyte-derived DC (SDDC), and bone marrow-derived DC were analyzed
(n = 3 animals/group). Bar graphs show (A) frequencies of MHC-IIhigh cells among
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CD11c+ cells, and (B) mean fluorescence intensity (MFI) of MHC-IIint and
MHC-IIhigh populations (mean (SD)). (C–E) C57BL/6 mice were stimulated with
CpG-ODN (CpG; n = 5 animals) and analyzed at day 6 post treatment or were left
untreated (mock; n = 3 animals). Dot blots show gating strategy for splenocytes
(C) stained with the indicated lineage markers, (D) upstream of
TER119+CD11chigh cells, and (E) for sorting of TER119+CD11a−CD11c− and
TER119+CD11a+CD11c− cell populations. Data of the animal representing the
group median are shown. Numbers indicate mean proportion of gated cells (SD).
(F) C57BL/6 mice were stimulated with CpG-ODN and bone marrow cells were
examined by flow cytometry at day 6 post treatment. Dot blots show surface
phenotype of CD3−CD19− bone marrow cells. Data of the animal representing
the median of n = 5 animals are shown.
Figure S2 | Differential effect of CD115 blockade on myeloid cell populations.
CpG-ODN-treated mice were injected with anti-CD115 antibody or isotype
control. Graphs show numbers of macrophages and DC in spleen at day 6 post
CpG-ODN treatment. n = 4 animals/group (mean (SD)). Student’s t test was
performed. Statistical significance is indicated by ∗∗∗ = p < 0.0001, ns = p > 0.05.
Figure S3 | Expression of TER119 on CD11c+ cells in the draining lymph node.
Mice were injected with a single dose of CpG-ODN into one footpad. At day 10
post stimulation, the draining popliteal lymph nodes were harvested. Single cell
suspensions from 5 mice were pooled and enriched for CD11c+ cells using
magnetic beads. Dot blots show staining with antibodies against CD11c and with
TER119 or isotype control antibody.
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